Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/25916
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorÁvila Gómez, Isabel Cristina-
dc.contributor.authorVélez Pardo, Carlos Alberto-
dc.contributor.authorJiménez del Río, Marlene-
dc.date.accessioned2022-02-09T15:53:16Z-
dc.date.available2022-02-09T15:53:16Z-
dc.date.issued2009-
dc.identifier.issn1742-7835-
dc.identifier.urihttp://hdl.handle.net/10495/25916-
dc.description.abstractABSTRACT: Human peripheral blood lymphocytes have been useful as a putative model of oxidative stress-induced apoptosisfor Parkinson’s disease. The present work shows that rotenone, a mitochondrial complex I inhibitor, induced time- and con-centration-dependent apoptosis in lymphocytes which was mediated by anion superoxide radicals (O2•)) ⁄ hydrogen peroxide,depolarization of mitochondria, caspase-3 activation, concomitantly with the nuclear translocation of transcription factorssuch as NF-jB, p53, c-Jun and nuclei fragmentation. Since insulin-like growth factor-1 (IGF-1) interferes with a cell’s apopto-tic machinery when subjected to several stressful conditions, it is demonstrated here for the first time that IGF-1 effectivelyprotects lymphocytes against rotenone through PI-3K ⁄ Akt activation, down-regulation of p53 and maintenance of mitochon-drial membrane potential independently of ROS generation. These data might contribute to understanding the role played byIGF-1 against oxidative stress stimulispa
dc.format.extent9spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherWileyspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleEffects of Insulin-Like Growth Factor-1 on Rotenone-InducedApoptosis in Human Lymphocyte Cellsspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Neurociencias de Antioquiaspa
dc.identifier.doi10.1111/j.1742-7843.2009.00472.x-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1742-7843-
oaire.citationtitleBasic and Clinical Pharmacology and Toxicologyspa
oaire.citationstartpage53spa
oaire.citationendpage61spa
oaire.citationvolume106spa
oaire.citationissue1spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.publisher.placeCopenhague, Dinamarcaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsApoptosis-
dc.subject.decsLinfocitos-
dc.subject.decsLymphocytes-
dc.subject.decsRotenona-
dc.subject.decsRotenone-
dc.subject.decsInsulina-
dc.subject.decsInsulin-
dc.description.researchgroupidCOL0010744spa
dc.relation.ispartofjournalabbrevBasic Clin. Pharmacol. Toxicol.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
AvilaIsabel_2009_InsulinaApoptosisLinfocitos.pdfArtículo de investigación805.32 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons